达比加群（Pradaxa(®)）：外科医生的朋友还是敌人？
Dabigatran (Pradaxa(®)): surgeon's friend or foe?
作者信息
Syyed N, Ansell M, Sood V
机构信息
StR, Oral and Maxillofacial Unit Monkscourt Avenue, Airdrie, ML6 0JS.
Monklands Hospital, Monkscourt Avenue, Airdrie, ML6 0JS.
出版信息
Br Dent J. 2014 Dec 5;217(11):623-6. doi: 10.1038/sj.bdj.2014.1051.
PMID:25476635
Abstract
All clinicians, whether in primary or secondary care settings, are likely to encounter patients on this new anticoagulant. Therefore, it is imperative that clinicians are aware of the risks and benefits associated with dabigatran.
摘要
所有临床医生，无论在初级还是二级护理环境中，都可能会遇到正在使用这种新型抗凝剂的患者。因此，临床医生必须了解与达比加群相关的风险和益处。
Zotero 插件